
Psychosomatics 48:319-324, August 2007
doi: 10.1176/appi.psy.48.4.319
© 2007 Academy of Psychosomatic Medicine
Major Depressive Disorder and Inflammatory Markers in Elderly Patients With Heart Failure
Anna Maria Andrei, M.D., Ph.D.,
Renerio Fraguas, Jr., M.D., Ph.D.,
Renata M.S. Telles, M.D.,
Tânia C.T.F. Alves, M.D., Ph.D.,
Celia M.C. Strunz, M.D., Ph.D.,
Amit Nussbacher, M.D.,
Jairo Rays, M.D., Ph.D.,
Dan V. Iosifescu, M.D., and
Mauricio Wajngarten, M.D., Ph.D.
Received September 19, 2005; revised February 24, 2006; accepted March 8, 2006. From the Heart Institute, University of São Paulo School of Medicine, São Paulo, SP, Brazil; Massachusetts General Hospital, Department of Psychiatry, Boston, MA; Department and Institute of Psychiatry, University of São Paulo School of Medicine, São Paulo, SP, Brazil. Address correspondence and reprint requests to Dr. Fraguas. e-mail: rfraguas{at}partners.org
© 2007 The Academy of Psychosomatic Medicine
The authors evaluated levels of inflammatory markers in 34 chronic heart failure (CHF) out-patients age 65 years and over, with (N=18) and without (N=16) major depressive disorder (MDD), and healthy-control subjects (N=13). Patients with CHF had left-ventricular ejection fractions <0.40 and were in the New York Heart Association functional class II or III. The authors used the SCID DSMIV to diagnosis MDD. High-sensitivity C-reactive protein levels were significantly higher in patients with CHF and MDD as compared with healthy-control subjects. No differences regarding tumor necrosis factor or interleukin6 were found among the three groups.
Get information about faster international access.
a>
Privacy Policy
Copyright © 2007
Academy of Psychosomatic Medicine.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|